• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用计算机模拟转化方法研究高Gleason评分及局限性/局部进展性前列腺癌患者的独特生物学特征

Unique Biological Characteristics of Patients with High Gleason Score and Localized/Locally Advanced Prostate Cancer Using an In Silico Translational Approach.

作者信息

Miyachi Shiori, Oshi Masanori, Sasaki Takeshi, Endo Itaru, Makiyama Kazuhide, Inoue Takahiro

机构信息

Department of Nephro-Urologic Surgery and Andrology, Mie University Graduate School of Medicine, Tsu 514-8507, Mie, Japan.

Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Kanagawa, Japan.

出版信息

Curr Oncol. 2025 Jul 18;32(7):409. doi: 10.3390/curroncol32070409.

DOI:10.3390/curroncol32070409
PMID:40710219
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12294092/
Abstract

Gleason score (GS) is one of the best predictors of prostate cancer (PCa) aggressiveness; however, its biological features need to be elucidated. This study aimed to explore the biological characteristics of localized/locally advanced PCa stratified using in silico GS analysis. Biological features were analyzed using gene set variation analysis and the xCell algorithm with mRNA expression in two independent public databases: The Cancer Genome Atlas (TCGA) ( = 493; radical prostatectomy cohort) and GSE116918 ( = 248; radiation therapy cohort). GS levels were positively correlated with the activity levels of cell proliferation-related gene sets, including E2F targets, the G2M checkpoint, the mitotic spindle, and MYC targets v1 and v2 in both cohorts. Furthermore, GS levels were positively associated with the activity levels of immune-related gene sets and infiltrating fractions of immune cells, including CD4+ memory T cells, dendritic cells, M1 macrophages, and Th2 cells, in both cohorts. Notably, GS levels were positively associated with the score levels of homologous recombination defects, intratumor heterogeneity, fraction genome alteration, neoantigens, and mutation rates in the TCGA cohort. In conclusion, PCa with high GS levels was associated with cancer cell proliferation, immune cell infiltration, and high mutation rates, which may reflect worse clinical outcomes.

摘要

Gleason评分(GS)是前列腺癌(PCa)侵袭性的最佳预测指标之一;然而,其生物学特征仍需阐明。本研究旨在通过计算机模拟GS分析,探索局限性/局部进展性PCa分层后的生物学特征。在两个独立的公共数据库中,使用基因集变异分析和xCell算法,结合mRNA表达来分析生物学特征:癌症基因组图谱(TCGA)(n = 493;根治性前列腺切除术队列)和GSE116918(n = 248;放射治疗队列)。在两个队列中,GS水平均与细胞增殖相关基因集的活性水平呈正相关,这些基因集包括E2F靶点、G2M检查点、有丝分裂纺锤体以及MYC靶点v1和v2。此外,在两个队列中,GS水平均与免疫相关基因集的活性水平以及免疫细胞的浸润分数呈正相关,这些免疫细胞包括CD4 + 记忆T细胞、树突状细胞、M1巨噬细胞和Th2细胞。值得注意的是,在TCGA队列中,GS水平与同源重组缺陷、肿瘤内异质性、基因组改变分数、新抗原和突变率的评分水平呈正相关。总之,高GS水平的PCa与癌细胞增殖、免疫细胞浸润和高突变率相关,这可能反映出更差的临床结局。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00aa/12294092/d6ceddaa8df3/curroncol-32-00409-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00aa/12294092/1df873546b2b/curroncol-32-00409-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00aa/12294092/ff8a2b7521ad/curroncol-32-00409-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00aa/12294092/deab11619277/curroncol-32-00409-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00aa/12294092/dcb9fb2db53a/curroncol-32-00409-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00aa/12294092/9310909aa7e2/curroncol-32-00409-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00aa/12294092/d6ceddaa8df3/curroncol-32-00409-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00aa/12294092/1df873546b2b/curroncol-32-00409-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00aa/12294092/ff8a2b7521ad/curroncol-32-00409-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00aa/12294092/deab11619277/curroncol-32-00409-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00aa/12294092/dcb9fb2db53a/curroncol-32-00409-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00aa/12294092/9310909aa7e2/curroncol-32-00409-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00aa/12294092/d6ceddaa8df3/curroncol-32-00409-g006.jpg

相似文献

1
Unique Biological Characteristics of Patients with High Gleason Score and Localized/Locally Advanced Prostate Cancer Using an In Silico Translational Approach.使用计算机模拟转化方法研究高Gleason评分及局限性/局部进展性前列腺癌患者的独特生物学特征
Curr Oncol. 2025 Jul 18;32(7):409. doi: 10.3390/curroncol32070409.
2
Prognostic and immunological implications of cathepsin Z overexpression in prostate cancer.组织蛋白酶Z在前列腺癌中过表达的预后及免疫学意义
Front Immunol. 2025 Jun 11;16:1618487. doi: 10.3389/fimmu.2025.1618487. eCollection 2025.
3
Neo-adjuvant and adjuvant hormone therapy for localised and locally advanced prostate cancer.局限性和局部晚期前列腺癌的新辅助和辅助激素治疗
Cochrane Database Syst Rev. 2006 Oct 18;2006(4):CD006019. doi: 10.1002/14651858.CD006019.pub2.
4
Impact of Gleason score on biochemical recurrence in patients with pT3aN0/Nx prostate cancer with positive surgical margins: a multicenter study from the Prostate Cancer Research Committee.Gleason评分对手术切缘阳性的pT3aN0/Nx前列腺癌患者生化复发的影响:来自前列腺癌研究委员会的一项多中心研究
J Cancer Res Clin Oncol. 2017 Nov;143(11):2393-2400. doi: 10.1007/s00432-017-2502-7. Epub 2017 Aug 19.
5
Performance of apparent diffusion coefficient values and ratios for the prediction of prostate cancer aggressiveness across different MRI acquisition settings.在不同 MRI 采集设置下,表观扩散系数值和比值对预测前列腺癌侵袭性的性能。
Diagn Interv Radiol. 2022 Jan;28(1):12-20. doi: 10.5152/dir.2022.20732.
6
Increased GPR35 expression is correlated with poor prognosis in prostate cancer.GPR35表达增加与前列腺癌预后不良相关。
World J Surg Oncol. 2025 Jun 18;23(1):239. doi: 10.1186/s12957-025-03893-0.
7
Early versus deferred androgen suppression in the treatment of advanced prostatic cancer.晚期前列腺癌治疗中早期与延迟雄激素抑制疗法的比较
Cochrane Database Syst Rev. 2002(1):CD003506. doi: 10.1002/14651858.CD003506.
8
A systematic overview of radiation therapy effects in prostate cancer.前列腺癌放射治疗效果的系统综述。
Acta Oncol. 2004;43(4):316-81. doi: 10.1080/02841860410030661.
9
MRI software and cognitive fusion biopsies in people with suspected prostate cancer: a systematic review, network meta-analysis and cost-effectiveness analysis.磁共振成像软件联合认知融合活检用于疑似前列腺癌患者:系统评价、网络荟萃分析和成本效果分析。
Health Technol Assess. 2024 Oct;28(61):1-310. doi: 10.3310/PLFG4210.
10
Polygenic Risk Score and Upgrading in Patients With Prostate Cancer Receiving Active Surveillance.多基因风险评分与接受主动监测的前列腺癌患者的病情进展
JAMA Oncol. 2025 Feb 1;11(2):168-171. doi: 10.1001/jamaoncol.2024.5398.

本文引用的文献

1
Screening for Predictive Factors of Efficacy of Second-Generation Androgen Receptor Axis-Targeted Agents in Patients With High-Risk Metastatic Hormone-Sensitive Prostate Cancer.高危转移性激素敏感性前列腺癌患者中第二代雄激素受体轴靶向药物疗效预测因素的筛查
Prostate. 2025 May;85(6):524-530. doi: 10.1002/pros.24855. Epub 2025 Jan 15.
2
Relationship Between Loss of Y Chromosome and Urologic Cancers: New Future Perspectives.Y染色体缺失与泌尿系统癌症之间的关系:新的未来展望。
Cancers (Basel). 2024 Nov 8;16(22):3766. doi: 10.3390/cancers16223766.
3
Exploring the interaction between immune cells in the prostate cancer microenvironment combining weighted correlation gene network analysis and single-cell sequencing: An integrated bioinformatics analysis.
结合加权相关基因网络分析和单细胞测序探索前列腺癌微环境中免疫细胞之间的相互作用:一项综合生物信息学分析
Discov Oncol. 2024 Sep 30;15(1):513. doi: 10.1007/s12672-024-01399-x.
4
Precision molecular insights for prostate cancer prognosis: tumor immune microenvironment and cell death analysis of senescence-related genes by machine learning and single-cell analysis.前列腺癌预后的精准分子见解:通过机器学习和单细胞分析对衰老相关基因进行肿瘤免疫微环境和细胞死亡分析
Discov Oncol. 2024 Sep 27;15(1):487. doi: 10.1007/s12672-024-01277-6.
5
UQCRB and LBH are correlated with Gleason score progression in prostate cancer: Spatial transcriptomics and experimental validation.UQCRB和LBH与前列腺癌的Gleason评分进展相关:空间转录组学及实验验证。
Comput Struct Biotechnol J. 2024 Aug 30;23:3315-3326. doi: 10.1016/j.csbj.2024.08.026. eCollection 2024 Dec.
6
Establishment of a prognostic risk model for prostate cancer based on Gleason grading and cuprotosis related genes.基于 Gleason 分级和铜死亡相关基因建立前列腺癌预后风险模型。
J Cancer Res Clin Oncol. 2024 Aug 1;150(8):376. doi: 10.1007/s00432-024-05899-9.
7
Urological cancer statistics on incidence from 1975 to 2019 and mortality from 1958 to 2022 in Japan.日本 1975 年至 2019 年泌尿生殖系统癌症发病率统计和 1958 年至 2022 年死亡率统计。
Int J Clin Oncol. 2024 Aug;29(8):1088-1095. doi: 10.1007/s10147-024-02575-3. Epub 2024 Jul 2.
8
Advances in sequencing and omics studies in prostate cancer: unveiling molecular pathogenesis and clinical applications.前列腺癌测序与组学研究进展:揭示分子发病机制及临床应用
Front Oncol. 2024 May 10;14:1355551. doi: 10.3389/fonc.2024.1355551. eCollection 2024.
9
Analysis of the Gene Networks and Pathways Correlated with Tissue Differentiation in Prostate Cancer.分析与前列腺癌组织分化相关的基因网络和途径。
Int J Mol Sci. 2024 Mar 24;25(7):3626. doi: 10.3390/ijms25073626.
10
Targeting the tumor microenvironment, a new therapeutic approach for prostate cancer.靶向肿瘤微环境,一种前列腺癌的新治疗方法。
Prostate Cancer Prostatic Dis. 2024 Apr 2. doi: 10.1038/s41391-024-00825-z.